Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan and Simmitecan, 5-fluorouracil and Leucovorin Calcium, in Patients With Advanced Solid Tumors

Trial Profile

Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan and Simmitecan, 5-fluorouracil and Leucovorin Calcium, in Patients With Advanced Solid Tumors

Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Jul 2017

At a glance

  • Drugs Simmitecan (Primary) ; Fluorouracil; Folinic acid
  • Indications Colorectal cancer; Solid tumours
  • Focus Pharmacokinetics
  • Sponsors ShangHai HaiHe Pharmaceutical
  • Most Recent Events

    • 18 Jul 2017 Number of arms of the study has increased from 4 to 6,hence number of planned patient number has also changed from 153 to243.
    • 11 Jul 2017 Planned number of patients changed from 158 to 243.
    • 11 Jul 2017 Planned End Date changed from 1 Oct 2018 to 1 Dec 2020.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top